Search

everythinglearnresearchcommunity

for

Search:↓

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Ulcerative colitis can cause skin issues due to immune system problems.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Dupilumab for skin problems might reactivate hair loss in some patients.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

ILC1 cells contribute to hair loss in alopecia areata.

Higher CRBP1 levels are linked to more severe alopecia areata.

Belimumab effectively controls SLE disease activity and reduces steroid use.